Print page  Contact  Frontpage






Recent News
7TM Pharma successfully conducts clinical Phase I trial of its first in class peripheral CB1 receptor antagonist TM38837 demonstrating restriction from the human CNS
Press Release Thursday, November 11, 2010
7TM Pharma completes positron emission tomography preclinical research program to successfully demonstrate peripheral restriction of its CB1 receptor antagonist TM38837
Press Release Monday, July 12, 2010
7TM Pharma receives milestone payment from asthma and allergy collaboration
Press Release Wednesday, May 26, 2010
Meet us